Biologicals
短名 | Biologicals. |
Journal Impact | 1.42 |
国际分区 | PHARMACOLOGY & PHARMACY(Q3) |
期刊索引 | SCI Q4中科院 4 区 |
ISSN | 1045-1056, 1095-8320 |
h-index | 66 |
国内分区 | 生物学(4区)生物学生化研究方法(4区)生物学生物工程与应用微生物(4区)生物学药学(4区) |
BIOLOGICALS 为人类和兽医学中使用的生物制品各个方面的新闻、辩论和原创研究提供了一个现代和多学科的国际论坛。该杂志发表与源自新颖和成熟生物技术的生物的开发、生产、质量控制和标准化相关的原始论文、评论和信件。制作特刊以反映国际上特别感兴趣和关注的主题。欢迎三种类型的论文:原创研究报告、短论文和评论文章。该杂志还将发表评论和致编辑的信件、书评、会议报告和监管问题信息。
期刊主页投稿网址涉及主题 | 生物医学遗传学化学免疫学生物化学病毒学抗体病理内科学基因病毒抗原物理微生物学计算机科学免疫系统 |
出版信息 | 出版商: Academic Press,出版周期: Quarterly,期刊类型: journal |
基本数据 | 创刊年份: 1990,原创研究文献占比: 96.88%,自引率:13.30%, Gold OA占比: 42.52% |
平均审稿周期 | 网友分享经验:较慢,6-12周来源Elsevier官网:平均10.2周 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Evaluation of candidate International Standards for meningococcal capsular polysaccharide groups W and Y
2024-8-1
Risk management for viral clearance: A case study on adoption of platform validation approach and risk management of process changes
2024-8-1
From discovery to innovation in animal health: Maturing emerging technologies for industrial development
2024-8-1
It is time to reconsider the use of naturally-occurring endotoxins in endotoxin recovery studies: Part 2 of a BioPhorum harmonized endotoxin recovery study
2024-8-1
A species-independent indirect-ELISA for detection of antibodies to the non-structural protein 2B of foot-and-mouth disease virus
2024-8-1
Aims and Scope/Editorial Board/Publishing Details
2024-8-1
Current trends in development and manufacturing of higher-valent pneumococcal polysaccharide conjugate vaccine and its challenges
2024-7-24
Designing multi-epitope vaccine against human cytomegalovirus integrating pan-genome and reverse vaccinology pipelines
2024-7-13
COVID-19: A case for plasma derived natural anticoagulants?
2024-6-25
From eradication to re-emergence: The changing landscape of polio in the cVDPV2 era
2024-5-1
Aims and Scope/Editorial Board/Publishing Details
2024-5-1
Comparison of skeletal muscle decellularization protocols and recellularization with adipose-derived stem cells for tissue engineering
2024-5-1
Animal cell substrates for the production of biologicals: An introduction to WHO documents
2024-5-1
Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities
2024-5-1
Report of a collaborative study to establish the first Indian Pharmacopoeia reference standard for teriparatide
2024-5-1
An indirect ELISA for detecting anti-SARS-CoV-2 antibodies in human sera using a baculovirus-expressed recombinant nucleocapsid antigen
2024-5-1
Overview of regulatory frameworks on the national lot release of plasma-derived medicinal products in Korea
2024-5-1
pH inactivation of SARS-CoV-2 and SARS-CoV in virus spiked protein A eluates from a mAb purification process
2024-5-1
Design and computational evaluation of a novel multi-epitope hybrid vaccine against monkeypox virus: Potential targets and immunogenicity assessment for pandemic preparedness
2024-5-1
Validation of a next generation sequencing method for adventitious virus detection: Demonstration of sensitivity in multiple cell lines
2024-5-1
Circulation of yellow fever virus in Benin city, Edo state Nigeria
2024-4-8
Prevalence of viral agents causing swine reproductive failure in Korea and the development of multiplex real-time PCR and RT-PCR assays
2024-4-1
Outer membrane vesicles as nanovaccine candidates against pathogenic Leptospira in experimental Guinea pig model
2024-3-26
Standards for fecal microbiota transplant: Tools and therapeutic advances
2024-3-21
A validated polyclonal antiserum-based immunoassay for assessment of HPV 16 L1 relative potency
2024-2-1
Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report
2024-2-1
Ethical approval for controlled human infectious model clinical trial protocols – A workshop report
2024-2-1
Fourth Controlled Human Infection Model (CHIM) meeting – CHIMs in endemic countries, May 22–23, 2023
2024-2-1
Enabling the evaluation of COVID-19 vaccines with correlates of protection
2024-2-1
Molecular characterization of Anaplasma ovis Msp4 protein in strains isolated from ticks in Turkey: A multi-epitope synthetic vaccine antigen design against Anaplasma ovis using immunoinformatic tools
2024-2-1
Development of an ELISA for the detection of fowl adenovirus serotype −4 utilizing fiber protein
2024-2-1
The current status of the biosimilars landscape in China
2024-2-1
Fifty years of advancing biologicals and beyond
2024-2-1
Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis
2024-2-1
Efficient extraction of adventitious virus nucleic acid using commercially available methods
2024-2-1
Report for the Eighth Asian National Control Laboratory Network meeting in 2023: Self-sufficiency strategy of plasma-derived medicinal products and regulatory harmonisation
2024-2-1
Evaluation of next-generation sequencing performance for in vitro detection of viruses in biological products
2024-2-1
An antibody-free evaluation of an mRNA COVID-19 vaccine
2024-2-1
Adjuvant effects of novel water/oil emulsion formulations on immune responses against infectious bronchitis (IB) vaccine in mice
2024-2-1
Expression and purification of Hepatitis B virus core antigen using Escherichia coli and its utilization for the diagnosis of Hepatitis B virus infections
2024-2-1
Nano-emulsion encapsulation for the efficient delivery of bacteriophage therapeutics
2024-2-1
A rapid and simple sterility test method based on solid culture medium containing blood
2024-2-1
The role of real-world evidence for regulatory and public health decision-making for Accelerated Vaccine Deployment- a meeting report
2024-2-1
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023
2024-2-1
Viral clearance capability of monoclonal antibody purification
2024-2-1
Novel vaccine candidates of Bordetella pertussis identified by reverse vaccinology
2024-2-1
Aims and Scope/Editorial Board/Publishing Details
2024-2-1
An antibody-free evaluation of an mRNA COVID-19 vaccine
2023-12-14
Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis
2023-12-14
Adjuvant effects of novel water/oil emulsion formulations on immune responses against infectious bronchitis (IB) vaccine in mice
2023-12-14
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远